President-elect Joe Biden on Monday will focus on reviving a pandemic-battered U.S. economy as he prepares to take office, as outgoing President Donald Trump promised more lawsuits of the type that so far have failed to alter his election defeat.
With the number of coronavirus cases surging across the country, Biden will receive a briefing and give a speech in his home state of Delaware on rebuilding an economy that has suffered millions of job losses as the pandemic has killed more than 245,000 Americans.
Biden’s scientific advisers will meet this week with pharmaceutical companies developing vaccines to prevent COVID-19, a top aide to the president-elect said, in preparation for the logistical challenges of widespread vaccination after Biden, a Democrat, takes office on Jan. 20.
Trump, a Republican, briefly appeared to acknowledge defeat on Sunday only to backtrack, saying on Twitter that he concedes “nothing” and repeating his unfounded accusations of voter fraud.
He later promised on Twitter to file “big cases showing the unconstitutionality of the 2020 Election,” even though he has made no headway with his legal challenges in multiple states so far.
Election officials of both parties have said there is no evidence of major irregularities. Federal election security officials have decried “unfounded claims” and expressed “utmost confidence” in the integrity of the elections, according to a statement last week by the lead U.S. cybersecurity agency.
In another blow to Trump’s legal strategy, his campaign on Sunday dropped a major part of a lawsuit it had brought seeking to prevent Pennsylvania from certifying its results, narrowing the case to an issue affecting a small number of ballots. Biden won the state by more than 68,000 votes.
Biden beat Trump in the Nov. 3 election by the same 306-232 margin in the state-by-state Electoral College that Trump proclaimed a “landslide” when he won in 2016. The former vice president also won the national popular vote by at least 5.5 million votes, or 3.6 percentage points, with ballots still being counted.
Former President Barack Obama, a Democrat who campaigned against Trump, said it was past time for Trump to concede and criticized Republicans who also refuse to accept the victory of his former vice president.
“When your time is up, then it is your job to put the country first and think beyond your own ego”, Obama told the CBS News show “60 Minutes” in an interview that aired on Sunday.
“I’m more troubled by the fact that other Republican officials who clearly know better are going along with this”, Obama said.
More than a week after Biden was declared the victor by major news organizations based on state-by-state vote counts, the Trump administration has still not recognized him as president-elect, preventing his team from gaining access to government office space and funding normally provided to an incoming administration to ensure a smooth transition.
Biden’s top advisers warned that Trump’s refusal to begin a transition could jeopardize the battle against the virus and inhibit vaccine distribution planning.
The number of U.S. coronavirus cases passed 11 million on Sunday, up a million in a week and the fastest increase since the pandemic began.
“We are in a very dangerous period,” Dr. Michael Osterholm, a member of Biden’s COVID-19 Advisory Board and director of the University of Minnesota’s Center for Infectious Disease Research and Policy, told NBC’s “Meet the Press.”
Unless action is taken now, “we’re going to see these numbers grow substantially”, Osterholm warned. “Our future’s in our hands.”
Biden has promised to make the health crisis a top priority as president. Ron Klain, who will be White House chief of staff when Biden takes office on Jan. 20, said Biden’s scientific advisers would meet with Pfizer Inc and other drugmakers this week.
Pfizer said last week its vaccine candidate had proved more than 90% effective in initial trials, giving hope that widespread vaccination in the coming months could help get the pandemic under control. Other companies also are in advanced stages of developing promising vaccines.